Hello, everyone, and top of the morning to you. Another shiny day is unfolding here on the Pharmalot corporate campus, where we are hustling the short people off to their various school houses for some learning. And this marathon calls for a much needed cup of stimulation - our flavor today is Cinnamon Cream Swirl. Please join us as we also peruse the news for interesting developments. As always, we encourage you to contact us if you hear of something noteworthy. Meanwhile, have a great day...
Teva Says Docs Contacted For Generic Copaxone Study (Bloomberg News)
FDA Accepts Application For Astra & Bristol Diabetes Drug (Associated Press)
FTC Takes Aim At Patent Trolls (Legal Times)
Hospira Names Allergan Exec As New CEO (Associated Press)
Berwick Appears Unlikely To Remain CMS Chief (New York Times)
Actelion Board Gets Boost From Major Investor (Pharma Times)
Repligen Stock Plunges On Failed Bipolar Drug Study (Boston Business Journal)